Related Experiment Video
Updated: May 4, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 9, 2014
Re-engineering bone: pathogenesis, diagnosis and emerging therapies for osteoporosis
Xinyi Dong1,2, Hao Liu1,2, Dian Yuan3
1Central Laboratory, Peking University School and Hospital of Stomatology, Beijing 100081, China. orthoyan@bjmu.edu.cn.
Tissue engineering offers a promising alternative to traditional osteoporosis treatments by addressing the disease's complex pathogenesis. This review explores advanced biomaterials and therapies for improved osteoporosis management.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Orthopedics
Background:
- Osteoporosis is a prevalent metabolic bone disease with significant healthcare implications.
- Traditional pharmacotherapy for osteoporosis has limitations, driving the need for alternative treatments.
- Understanding the pathogenesis, including abnormal microenvironments, is crucial for developing effective strategies.
Purpose of the Study:
- To review the pathogenesis of osteoporosis and current diagnostic techniques.
- To evaluate advanced tissue engineering strategies for osteoporosis treatment.
- To provide insights into future directions for tissue engineering-based osteoporosis management.
Main Methods:
- Comprehensive literature review of osteoporosis pathogenesis and diagnostics.
- Analysis of tissue engineering approaches, including delivery systems (hydrogels, nanomaterials).
- Evaluation of bone tissue engineering materials (ceramics, cements, polymers) and bioactive substances (exosomes, cytokines).
Main Results:
- Tissue engineering presents a viable alternative to conventional osteoporosis treatments.
- Various biomaterials and delivery systems show potential for bone regeneration.
- Emerging therapies include exosomes, cytokines, and small-molecule drugs.
Conclusions:
- Tissue engineering strategies offer innovative solutions for osteoporosis management.
- Further research into biomaterials and therapeutic approaches is needed for clinical translation.
- This review synthesizes current advancements to guide future research and clinical applications.
More Related Videos
Related Concept Videos
What is the Skeletal System?
Bone Remodeling
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

